Related Experiment Video
Updated: Aug 7, 2026
12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Discovery of cancer vaccination protocols with a genetic algorithm driving an agent based simulator
Pier-Luigi Lollini1, Santo Motta, Francesco Pappalardo
1Sezione di Cancerologia, Dipartimento di Patologia Sperimentale, University of Bologna, Italy. pierluigi.lollini@unibo.it
BMC Bioinformatics
|July 22, 2006
Summary
Researchers developed a simulator to optimize cancer vaccine schedules. The findings suggest that reducing vaccine administrations by 40% can still achieve maximal protection, potentially simplifying cancer immunoprevention strategies.
Area of Science:
- Immunology
- Computational Biology
- Oncology
Background:
- Cancer immunological prevention achieved in HER-2/neu transgenic mice using a Triplex vaccine.
- The need to determine the minimal vaccination schedule for 100% protection versus lifespan administration (Chronic protocol).
Purpose of the Study:
- To develop a simulator (SimTriplex) modeling the immune response to the Triplex vaccine.
- To use computational methods to identify optimal, potentially shorter, vaccination schedules.
Main Methods:
- Development of the SimTriplex simulator, validated against in vivo experiments.
- Application of a genetic algorithm with a minimal search strategy to explore vaccination protocols.
Main Results:
- The simulator accurately reproduces in vivo vaccination protocols.
- Results indicate that the Chronic protocol had redundant vaccine administrations.
- Maximal protection is achievable with approximately 40% fewer vaccinations than the Chronic protocol.
Conclusions:
- The computational approach can identify reduced vaccination schedules for cancer immunoprevention.
- This strategy may have significant implications for translating cancer immunoprevention to human applications by minimizing vaccine doses.
- Experimental validation of the genetic algorithm's proposed vaccination protocols is underway.
Related Concept Videos
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.